Results 51 to 60 of about 2,453,246 (260)

Medicare Prescription Drug Plans in 2008 and Key Changes Since 2006: Summary of Findings [PDF]

open access: yes, 2008
Synthesizes findings from prior research on the scope and generosity of drug coverage under Medicare Part D, as well as on changes in drug coverage and costs since 2006.
Elizabeth Hargrave   +3 more
core  

The price of tumor control [PDF]

open access: yes, 2013
Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces adverse events (AE) in up to 64% of patients.
Bergmann, Tanja   +35 more
core   +1 more source

Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 4)

open access: yesZdorovʹe Rebenka, 2018
The review of the literature presents mo­dern data on antioxidant vitamins — ascorbic acid and toco­pherol. Their antioxidant activity and immunomodulatory action in diseases of the respiratory system is shown.
A.E. Abaturov   +2 more
doaj   +1 more source

Clinical outcomes and treatment patterns of older adults with dementia-related psychosis by dementia type in the United States

open access: yesBMC Geriatrics, 2022
Background Little is known about the incidence of clinical events and treatment patterns among older adults with dementia-related psychosis. Given that dementia-related psychosis comprises various dementia types, this study describes the incidence of ...
Joan Forns   +7 more
doaj   +1 more source

New and Improved Diagnostics for Detection of Drug-Resistant Pulmonary Tuberculosis. [PDF]

open access: yes, 2011
PURPOSE OF REVIEW: Tuberculosis (TB) remains a global emergency and continues to kill 1.7 million people globally each year. Drug-resistant TB is now well established throughout the world and most TB patients are not being screened for drug resistance ...
Affolabi   +41 more
core   +1 more source

Off-label use catalogue of tumor anti-angiogenic drugs in China: a narrative review

open access: yesFrontiers in Pharmacology
BackgroundThe management of off-label use (OLU) is an important aspect of standardizing and promoting the rational use of antitumor drugs. Tumor anti-angiogenic therapy (AAT) is essential in cancer treatment.
Difei Yao   +13 more
doaj   +1 more source

Antioxidant properties of drugs used in Type 2 diabetes management: could they contribute to, confound or conceal effects of antioxidant therapy?

open access: yesRedox Report, 2018
Objectives: This is a narrative review, investigating the antioxidant properties of drugs used in the management of diabetes, and discusses whether these antioxidant effects contribute to, confound, or conceal the effects of antioxidant therapy. Methods:
Siu Wai Choi, Cyrus K. Ho
doaj   +1 more source

Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 6)

open access: yesZdorovʹe Rebenka, 2018
The review of the literature presents mo­dern data on antioxidant and anti-inflammatory acti­vity of polyphenols, as well as their representatives curcumin and resveratrol in diseases of the respiratory system.
A.E. Abaturov   +2 more
doaj   +1 more source

Managing Medicaid Pharmacy Benefits: Current Issues and Options [PDF]

open access: yes, 2011
Examines issues and considerations for state reforms of Medicaid prescription drug reimbursement, pharmacy management, and cost sharing and other best practices for realizing ...
Robin Rudowitz   +2 more
core  

Analysis of Medication Inventory System for Intensive Care Unit: A Hospital Example

open access: yesTürk Yoğun Bakim Derneği Dergisi
Objective: Optimizing health benefits becomes essential given the limitations of universal healthcare resources. Therefore, this study aims to conduct an always, better, and control (ABC) and vital, essential, and desirable (VED) analysis of medications ...
Alkan Durmuş   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy